Exanta - Oral Direct Thrombin Inhibitor for the Prevention and Treatment of Venous Thromboembolism

Print-Icon
Print

VTE encompasses both DVT and PE and is the third most common cardiovascular disease after heart attack and stroke.
 
«Back | Next»



| 1 | 2 | 3 |

Browse More Images - Return to Project




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development